Business · 08/10/2015

FDA Announces Proposed Collection of Information for Prescription Drug User Fee Act Products

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, as part of its guidance for formal meetings with sponsors and applicants for prescription drug products.